Recent publications · Crossref
5 total works indexed
- Sorafenib in Advanced Hepatocellular Carcinoma
· 2008 · cited 11,233x
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
· 2024 · cited 4,501x
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
· 2018 · cited 4,046x
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
· 2024 · cited 2,555x
- Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
· 2024 · cited 2,545x
via Crossref · CC0